- Home
- RNST vs LNTH Comparison
RNST vs LNTH Comparison
Compare RNST & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNST
- LNTH
- Stock Information
- Founded
- RNST 1904
- LNTH 1956
- Country
- RNST United States
- LNTH United States
- Employees
- RNST N/A
- LNTH N/A
- Industry
- RNST Major Banks
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RNST Finance
- LNTH Health Care
- Exchange
- RNST Nasdaq
- LNTH Nasdaq
- Market Cap
- RNST 3.7B
- LNTH 3.8B
- IPO Year
- RNST N/A
- LNTH 2015
- Fundamental
- Price
- RNST $34.77
- LNTH $50.52
- Analyst Decision
- RNST Strong Buy
- LNTH Buy
- Analyst Count
- RNST 6
- LNTH 6
- Target Price
- RNST $43.17
- LNTH $74.17
- AVG Volume (30 Days)
- RNST 587.2K
- LNTH 1.4M
- Earning Date
- RNST 10-28-2025
- LNTH 11-06-2025
- Dividend Yield
- RNST 2.65%
- LNTH N/A
- EPS Growth
- RNST N/A
- LNTH N/A
- EPS
- RNST 1.84
- LNTH 2.39
- Revenue
- RNST $775,309,000.00
- LNTH $1,525,933,000.00
- Revenue This Year
- RNST $43.22
- LNTH N/A
- Revenue Next Year
- RNST $12.94
- LNTH $1.98
- P/E Ratio
- RNST $18.92
- LNTH $21.18
- Revenue Growth
- RNST 13.04
- LNTH 1.95
- 52 Week Low
- RNST $26.97
- LNTH $47.25
- 52 Week High
- RNST $40.40
- LNTH $111.29
- Technical
- Relative Strength Index (RSI)
- RNST 47.08
- LNTH 34.98
- Support Level
- RNST $33.77
- LNTH $54.76
- Resistance Level
- RNST $34.68
- LNTH $61.92
- Average True Range (ATR)
- RNST 0.82
- LNTH 2.37
- MACD
- RNST 0.15
- LNTH -0.68
- Stochastic Oscillator
- RNST 64.53
- LNTH 3.44
About RNST Renasant Corporation
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.